Royalty Pharma plc (MUN:RPD)
Germany · Delayed Price · Currency is EUR 33.60
-0.24 (-0.71%)
At close: Nov 21, 2025
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of €14.46 billion as of November 21, 2025. Its market cap has increased by 31.11% in one year.
Market Cap
14.46B
Enterprise Value
24.21B
Revenue
2.00B
Ranking
n/a
PE Ratio
22.18
Stock Price
€33.60
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from 14.00B to 14.46B, an increase of 3.28%. That is a compound annual growth rate of 0.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 14.46B | 32.08% |
| Dec 31, 2024 | 10.95B | -3.17% |
| Dec 29, 2023 | 11.31B | -30.69% |
| Dec 30, 2022 | 16.31B | 8.38% |
| Dec 31, 2021 | 15.05B | -5.23% |
| Dec 31, 2020 | 15.88B | 13.43% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 239.33B |
| Siemens Aktiengesellschaft | 169.28B |
| Allianz SE | 136.62B |
| Deutsche Telekom AG | 129.38B |
| Siemens Energy AG | 92.82B |
| Rheinmetall AG | 73.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.84B |
| Deutsche Bank Aktiengesellschaft | 56.97B |